Mark E. Cooper
Beth Israel Deaconess Medical Center(US)Baker Heart and Diabetes Institute(AU)University of South Florida(US)Diabetes Australia(AU)Australian Regenerative Medicine Institute(AU)InfoConsult (Germany)(DE)Alfred Health(AU)Monash University(AU)
Publications by Year
Research Areas
Chronic Kidney Disease and Diabetes, Advanced Glycation End Products research, Diabetes Treatment and Management, Blood Pressure and Hypertension Studies, Renin-Angiotensin System Studies
Most-Cited Works
- → Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy(2001)7,433 cited
- → Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes(2008)7,365 cited
- → Mechanisms of Diabetic Complications(2013)2,734 cited
- → A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease(2009)2,057 cited
- → Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future(2013)1,719 cited
- → Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes(2008)1,200 cited